Latest Insider Transactions at Alignment Healthcare, Inc. (ALHC)
This section provides a real-time view of insider transactions for Alignment Healthcare, Inc. (ALHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alignment Healthcare, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alignment Healthcare, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 26
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.84%
|
$130,000
$13.02 P/Share
|
|
Oct 03
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
20,000
-1.66%
|
$240,000
$12.03 P/Share
|
|
Sep 20
2022
|
Warburg Pincus Partners Gp LLC Director |
SELL
Open market or private sale
|
Indirect |
2,044,006
-10.24%
|
$28,616,084
$14.61 P/Share
|
|
Sep 20
2022
|
Warburg Pincus LLC Director |
SELL
Open market or private sale
|
Indirect |
2,044,006
-10.24%
|
$28,616,084
$14.61 P/Share
|
|
Sep 20
2022
|
General Atlantic (Aln Hlth), L.P. Director |
SELL
Open market or private sale
|
Indirect |
6,955,994
-10.24%
|
$97,383,916
$14.61 P/Share
|
|
Sep 20
2022
|
General Atlantic LLC Director |
SELL
Open market or private sale
|
Indirect |
6,955,994
-10.24%
|
$97,383,916
$14.61 P/Share
|
|
Sep 12
2022
|
Richard A. Cross SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
102,759
+20.41%
|
-
|
|
Sep 12
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
280,360
+18.85%
|
-
|
|
Sep 12
2022
|
Dawn Christine Maroney President, Markets |
BUY
Grant, award, or other acquisition
|
Direct |
431,323
+17.88%
|
-
|
|
Sep 12
2022
|
Robert Thomas Freeman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
319,179
+30.38%
|
-
|
|
Sep 12
2022
|
John E Kao Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,639,027
+40.38%
|
-
|
|
Sep 09
2022
|
Dawn Christine Maroney President, Markets |
SELL
Bona fide gift
|
Direct |
450
-0.03%
|
-
|
|
Sep 09
2022
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
10,250
-0.66%
|
$164,000
$16.6 P/Share
|
|
Sep 08
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
50,000
-5.12%
|
$800,000
$16.05 P/Share
|
|
Sep 01
2022
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
20,000
-1.27%
|
$280,000
$14.56 P/Share
|
|
Sep 01
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
30,000
-2.98%
|
$420,000
$14.56 P/Share
|
|
Sep 01
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-1.75%
|
$700,000
$14.56 P/Share
|
|
Sep 01
2022
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
24,000
-3.89%
|
$336,000
$14.56 P/Share
|
|
Aug 23
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
50,000
-4.73%
|
$800,000
$16.0 P/Share
|
|
Aug 23
2022
|
Warburg Pincus Partners Gp LLC Director |
SELL
Open market or private sale
|
Indirect |
682,000
-3.3%
|
$10,230,000
$15.5 P/Share
|
|
Aug 23
2022
|
Warburg Pincus LLC Director |
SELL
Open market or private sale
|
Indirect |
682,000
-3.3%
|
$10,230,000
$15.5 P/Share
|
|
Aug 23
2022
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
13,713
-0.86%
|
$205,695
$15.93 P/Share
|
|
Aug 22
2022
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
16,287
-1.01%
|
$244,305
$15.9 P/Share
|
|
Aug 15
2022
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
1,790
-0.11%
|
$28,640
$16.6 P/Share
|
|
Aug 11
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
500,000
-14.93%
|
$7,500,000
$15.95 P/Share
|
|
Aug 09
2022
|
Warburg Pincus Partners Gp LLC Director |
SELL
Open market or private sale
|
Indirect |
2,120,000
-9.31%
|
$33,920,000
$16.16 P/Share
|
|
Aug 09
2022
|
Warburg Pincus LLC Director |
SELL
Open market or private sale
|
Indirect |
2,120,000
-9.31%
|
$33,920,000
$16.16 P/Share
|
|
Aug 08
2022
|
General Atlantic (Aln Hlth), L.P. Director |
SELL
Open market or private sale
|
Indirect |
2,120,000
-3.03%
|
$33,920,000
$16.9 P/Share
|
|
Aug 08
2022
|
General Atlantic LLC Director |
SELL
Open market or private sale
|
Indirect |
2,120,000
-3.03%
|
$33,920,000
$16.9 P/Share
|
|
Aug 05
2022
|
Jeffrey H Margolis Director |
SELL
Open market or private sale
|
Indirect |
1,200
-0.28%
|
$21,600
$18.0 P/Share
|
|
Aug 05
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
44,104
-2.01%
|
$793,872
$18.76 P/Share
|
|
Aug 05
2022
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
43,410
-3.3%
|
$781,380
$18.76 P/Share
|
|
Aug 05
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
66,191
-0.97%
|
$1,191,438
$18.78 P/Share
|
|
Aug 02
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
848
-0.02%
|
$11,872
$14.74 P/Share
|
|
Aug 01
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
30,000
-2.65%
|
$420,000
$14.49 P/Share
|
|
Aug 01
2022
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
20,000
-1.23%
|
$280,000
$14.47 P/Share
|
|
Aug 01
2022
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
24,000
-3.51%
|
$336,000
$14.5 P/Share
|
|
Aug 01
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
49,152
-1.42%
|
$688,128
$14.6 P/Share
|
|
Jul 11
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
4,107
-0.12%
|
$57,498
$14.08 P/Share
|
|
Jul 08
2022
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
14,775
-0.9%
|
$206,850
$14.3 P/Share
|
|
Jul 08
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
20,699
-0.59%
|
$289,786
$14.33 P/Share
|
|
Jul 07
2022
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
25,225
-1.51%
|
$353,150
$14.12 P/Share
|
|
Jul 07
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
49,442
-0.7%
|
$692,188
$14.09 P/Share
|
|
Jul 06
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
25,752
-0.72%
|
$334,776
$13.04 P/Share
|
|
Jul 06
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
20,000
-1.74%
|
$260,000
$13.04 P/Share
|
|
Jul 05
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
16,317
-1.4%
|
$195,804
$12.41 P/Share
|
|
Jul 05
2022
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
20,383
-2.89%
|
$244,596
$12.48 P/Share
|
|
Jul 01
2022
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
12,000
-1.68%
|
$132,000
$11.4 P/Share
|
|
Jul 01
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.85%
|
$110,000
$11.4 P/Share
|
|
Jun 22
2022
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
100
-0.01%
|
$1,200
$12.0 P/Share
|